AI Article Synopsis

  • The NCoR corepressor is important for regulating gene expression by both nuclear receptors and non-receptor transcription factors, with different variants produced by alternative mRNA splicing having unique biological effects.
  • The NCoRω variant inhibits fat cell formation (adipogenesis) and its deletion in mice leads to increased fat in the liver, weight gain, and improved glucose tolerance on a high-fat diet, while NCoRδ shows the opposite effects.
  • Both splice variants influence a range of metabolic pathways related to fats, carbohydrates, and amino acids, highlighting how they work both separately and together to impact energy storage and usage in the body.

Article Abstract

The NCoR corepressor plays critical roles in mediating transcriptional repression by both nuclear receptors and non-receptor transcription factors. Alternative mRNA splicing of NCoR produces a series of variants with differing molecular and biological properties. The NCoRω splice-variant inhibits adipogenesis whereas the NCoRδ splice-variant promotes it, and mice bearing a splice-specific knockout of NCoRω display enhanced hepatic steatosis and overall weight gain on a high fat diet as well as a greatly increased resistance to diet-induced glucose intolerance. We report here that the reciprocal NCoRδ splice-specific knock-out mice display the contrary phenotypes of reduced hepatic steatosis and reduced weight gain relative to the NCoRω-/- mice. The NCoRδ-/- mice also fail to demonstrate the strong resistance to diet-induced glucose intolerance exhibited by the NCoRω-/- animals. The NCoR δ and ω variants possess both unique and shared transcriptional targets, with expression of certain hepatic genes affected in opposite directions in the two mutants, others altered in one but not the other genotype, and yet others changed in parallel in both NCoRδ-/- and NCoRω-/- animals versus WT. Gene set expression analysis (GSEA) identified a series of lipid, carbohydrate, and amino acid metabolic pathways that are likely to contribute to their distinct steatosis and glucose tolerance phenotypes. We conclude that alternative-splicing of the NCoR corepressor plays a key role in the regulation of hepatic energy storage and utilization, with the NCoRδ and NCoRω variants exerting both opposing and shared functions in many aspects of this phenomenon and in the organism as a whole.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588069PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241238PLOS

Publication Analysis

Top Keywords

ncor corepressor
12
corepressor plays
8
hepatic steatosis
8
weight gain
8
resistance diet-induced
8
diet-induced glucose
8
glucose intolerance
8
ncorω-/- animals
8
ncor
5
hepatic
5

Similar Publications

DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis.

Bone Res

December 2024

Department of Orthopedics, Northern Jiangsu People's Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, 98 West Nantong Road, Yangzhou, 225001, China.

Osteoporosis (OP) is a common and fracture-prone skeletal disease characterized by deteriorated trabecular microstructure and pathologically involving various forms of regulated bone cell death. However, the exact role, cellular nature and regulatory mechanisms of ferroptosis in OP are not fully understood. Here, we reported that OP femurs from ovariectomized (Ovx) mice exhibited pronounced iron deposition, ferroptosis, and transcriptional suppression of a key anti-ferroptotic factor GPX4 (glutathione peroxidase 4).

View Article and Find Full Text PDF

Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming.

Proc Natl Acad Sci U S A

October 2024

Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817.

Article Synopsis
  • Dysregulation of circadian rhythm (CR) is linked to cancer, with the study highlighting a major shift in the function of the CR regulator REV-ERBα in tumors.
  • REV-ERBα transitions from a gene repressor in normal tissues to a gene activator in cancer, activating many tumor-related signaling pathways through its partnership with other proteins like FOXA1.
  • Targeting REV-ERBα with the drug SR8278 can reduce its function and, when combined with BRD4 inhibitors, effectively suppress tumor growth by disrupting tumorigenic gene programs.
View Article and Find Full Text PDF

Forkhead box protein FOXK1 disrupts the circadian rhythm to promote breast tumorigenesis in response to insulin resistance.

Cancer Lett

September 2024

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China; Beijing Key Laboratory of Cancer Invasion and Metastasis Research, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China. Electronic address:

The dysregulation of circadian rhythm oscillation is a prominent feature of various solid tumors. Thus, clarifying the molecular mechanisms that maintain the circadian clock is important. In the present study, we revealed that the transcription factor forkhead box FOXK1 functions as an oncogene in breast cancer.

View Article and Find Full Text PDF

Histone deacetylases (HDACs) are important cancer drug targets. Existing FDA-approved drugs target the catalytic pocket of HDACs, which is conserved across subfamilies (classes) of HDAC. However, engineering specificity is an important goal.

View Article and Find Full Text PDF

De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder.

Am J Hum Genet

August 2024

Department of Pharmacology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Ischemic/hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Neuroscience Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Wide River Institute of Immunology, Seoul National University, Hongcheon, Republic of Korea; The Institute of Molecular Biology & Genetics, Seoul National University, Seoul, Republic of Korea. Electronic address:

Histone deacetylase 3 (HDAC3) is a crucial epigenetic modulator essential for various developmental and physiological functions. Although its dysfunction is increasingly recognized in abnormal phenotypes, to our knowledge, there have been no established reports of human diseases directly linked to HDAC3 dysfunction. Using trio exome sequencing and extensive phenotypic analysis, we correlated heterozygous de novo variants in HDAC3 with a neurodevelopmental disorder having variable clinical presentations, frequently associated with intellectual disability, developmental delay, epilepsy, and musculoskeletal abnormalities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!